titoli, abstracts, parole chiave >>>
Phytotherapy in the treatment of Benign Prostatic Hyperplasia (BPH): between evidence and empiricism

Morgia, Giuseppe and Madonia, Massimo and Russo, Giorgio Ivan (2012) Phytotherapy in the treatment of Benign Prostatic Hyperplasia (BPH): between evidence and empiricism. Clinical Pharmacology & Biopharmaceutics, Vol. 1 (2). eISSN 2167-065X. Article.

[img]Full text disponibile come PDF Richiede visualizzatore di PDF come GSview, Xpdf o Adobe Acrobat Reader
Available under License Creative Commons Attribution.

434Kb

DOI: 10.4172/cpb.1000e107

Abstract

The treatment of Benign Prostatic Hyperplasia (BPH) has been recently approved by different international guidelines like AUA, EAU, NICE, WHO consultation, etc, and drugs as the alpha-blockers and the 5-alpha-reductase inhibitors are widely indicated for this disease.
Moreover, little space is given to the anti-cholinergics and recently to the phosphodiesterase type 5 inhibitors.
In this field of application, the phytotherapics, in particular Serenoa repens, are less or not recommended, because they are not supported by adequate scientific evidence.
However, the use of these molecules is widely diffuse all over the world, achieving the first choice of treatment in some Nations such as the Asians.

Item Type:Article
ID Code:8890
Status:Published
Refereed:Yes
Uncontrolled Keywords:Benign Prostatic Hyperplasia (BPH), Serenoa repens, phytotherapy
Subjects:Area 06 - Scienze mediche > MED/24 Urologia
Divisions:001 Università di Sassari > 01-a Nuovi Dipartimenti dal 2012 > Scienze Chirurgiche, Microchirurgiche e Mediche
Publisher:OMICS
eISSN:2167-065X
Copyright Holders:© 2012 Morgia G et al.
Deposited On:18 Apr 2013 11:02

I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore

Repository Staff Only: item control page